The JAK2 V617F mutation in Philadelphia‐negative chronic myeloproliferative disorders

Ítems similars

• Prognostic significance of ASXL1, JAK2V617F mutations and JAK2V617F allele burden in Philadelphia-negative myeloproliferative neoplasms
  per: Yonal-Hindilerden, Ipek, et al.
  Publicat: (2015)
• Is JAK2V617F Mutation the Only Factor for Thrombosis in Philadelphia-Negative Chronic Myeloproliferative Neoplasms?
  per: Uyanik, Mehmet Sevki, et al.
  Publicat: (2015)
• Clinical Impact of JAK2V617F Allele Burden in Philadelphia-Negative Myeloproliferative Neoplasms
  per: İpek Yonal Hindilerden, et al.
  Publicat: (2023-08-01)
• Characterization and Prognosis Significance of JAK2 (V617F), MPL, and CALR Mutations in Philadelphia-Negative Myeloproliferative Neoplasms
  per: Singdong, Roongrudee, et al.
  Publicat: (2016)
• Coexistence of JAK2V617F and CALR mutation in Tunisian cohort with Philadelphia-negative chronic myeloproliferative neoplasms
  per: Hejer Elmahmoudi, et al.
  Publicat: (2023-01-01)